Curanex Pharmaceuticals Receives Nasdaq Delisting Warning for Low Share Price
I'm PortAI, I can summarize articles.
Curanex Pharmaceuticals Inc. has received a Nasdaq delisting warning due to its stock closing below the $1.00 minimum bid price for 30 consecutive business days. The company has until May 4, 2026, to regain compliance by maintaining the required price for ten consecutive days. Curanex's stock will continue to trade under the symbol "CURX" during this period, and it may be eligible for an additional 180-day extension if compliance is not achieved.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments